Page 1516 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Chapter 106Acute Liver FailureJulia Wendon

REFERENCES

1. Lee WM, Stravitz RT, Larson AM. Introduction to the revised 15. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen
American Association for the Study of Liver Diseases Position overdose. 662 cases with evaluation of oral acetylcysteine
Paper on acute liver failure 2011. Hepatology. 2012;55:965-967. treatment. Arch Intern Med. 1981;141:380-385.
2. Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look- 16. Craig DG, Bates CM, Davidson JS, Martin KG, Hayes PC,
back in acute liver failure? A single centre experience of 3300 Simpson KJ. Staggered overdose pattern and delay to hospital
patients. J Hepatol. 2013;59:74-80. presentation are associated with adverse outcomes follow-
3. O’Grady JG, Schalm SW, Williams R. Acute liver failure: rede- ing paracetamol-induced hepatotoxicity. Br J Clin Pharmacol.
fining the syndromes. Lancet. 1993;342:273-275. 2012;73:285-294.
4. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, 17. Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli-
Chamuleau RA. Systematic review: acute liver failure—one Vergani G, Dhawan A. Safety and efficacy of N-acetylcysteine in
disease, more than 40 definitions. Alimentary Pharmacol children with non-acetaminophen-induced acute liver failure.
Therapeut. 2012;35:1245-1256. Liver Transpl. 2008;14:25-30.
18. Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA,
5. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a pro-
spective study of acute liver failure at 17 tertiary care centers in Larsen FS. Comparison of terlipressin and noradrenalin on cere-
the United States. Ann Intern Med. 2002;137:947-954. bral perfusion, intracranial pressure and cerebral extracellular
concentrations of lactate and pyruvate in patients with acute liver
6. Myers RP, Shaheen AA, Li B, Dean S, Quan H. Impact of liver failure in need of inotropic support. J Hepatol. 2007;47:381-386.
disease, alcohol abuse, and unintentional ingestions on the out-
comes of acetaminophen overdose. Clin Gastroenterol Hepatol. 19. Harry R, Auzinger G, Wendon J. The effects of supraphysiologi-
2008;6:918-925; quiz 837. cal doses of corticosteroids in hypotensive liver failure. Liver Int.
2003;23:71-77.
7. Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl 20. Parekh NK, Hynan LS, De Lemos J, Lee WM, Acute Liver
J Med. 2008;359:285-292.
Failure Study G. Elevated troponin I levels in acute liver fail-
8. Lee WM, Hynan LS, Rossaro L, et al. Intravenous ure: is myocardial injury an integral part of acute liver failure?
N-acetylcysteine improves transplant-free survival in early Hepatology. 2007;45:1489-1495.
stage non-acetaminophen acute liver failure. Gastroenterology. 21. Audimooolam VK, McPhail MJ, Sherwood R, et al. Elevated
2009;137:856-864, 64 e1.
troponin I and its prognostic significance in acute liver failure.
9. Reuben A, Koch DG, Lee WM, Acute Liver Failure Study G. Critical care (London, England). 2012;16:R228.
Drug-induced acute liver failure: results of a U.S. multicenter, 22. Karvellas CJ, Pink F, McPhail M, et al. Bacteremia, acute physi-
prospective study. Hepatology. 2010;52:2065-2076. ology and chronic health evaluation II and modified end stage
10. Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS state- liver disease are independent predictors of mortality in critically
ment: hepatotoxicity of antituberculosis therapy. Am J Respir ill nontransplanted patients with acute on chronic liver failure.
Crit Care Med. 2006;174:935-952. Crit Care Med. 2010;38:121-126.
11. Lescot T, Karvellas C, Beaussier M, Magder S. Acquired liver injury 23. van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik
in the intensive care unit. Anesthesiology. 2012;117:898-904. TM. Clinical application of bioartificial liver support systems.
12. Torres HA, Davila M. Reactivation of hepatitis B virus and Ann Surg. 2004;240:216-230.
hepatitis C virus in patients with cancer. Nat Rev Clin Oncol. 24. Bernal W, Auzinger G, Wendon J. Prognostic utility of the
2012;9:156-166. bilirubin lactate and etiology score. Clin Gastroenterol Hepatol.
13. Mitka M. FDA: Increased HBV reactivation risk with ofatu- 2009;7:249; author reply.
mumab or rituximab. JAMA. 2013;310:1664. 25. Bernuau J. Selection for emergency liver transplantation. J
14. Hsu C, Hsiung CA, Su IJ, et al. A revisit of prophylactic lami- Hepatol. 1993;19:486-487.
vudine for chemotherapy-associated hepatitis B reactivation 26. Rutherford A, King LY, Hynan LS, et al. Development of an
in non-Hodgkin’s lymphoma: a randomized trial. Hepatology. accurate index for predicting outcomes of patients with acute
2008;47:844-853. liver failure. Gastroenterology. 2012;143:1237-1243.

Section09-O-Ref.indd 1 12/10/2014 6:09:24 PM